Lv4
570 积分 2021-11-10 加入
Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy
15天前
已完结
Maximizing the Conspicuity of CSF-Venous Fistulas on CT Myelography: Assessment of Contrast Density and Timing Effects
20天前
已完结
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
20天前
已完结
胆道恶性肿瘤转化治疗专家共识（2025）
1个月前
已完结
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study
1个月前
已完结
Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial
1个月前
已完结
Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with microvascular invasion: A randomised controlled trial
1个月前
已完结
肝细胞癌术后辅助治疗的进展与挑战
1个月前
已完结
Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis
1个月前
已完结
Preoperative prediction and risk assessment of microvascular invasion in hepatocellular carcinoma
1个月前
已完结
皖公网安备34019202002308
